wonder how much they were payed to write that rubbish what a disgrace buy at 65 now 47 and capital raising coming at probaly 35 to 40 cents a joke this company is becoming
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%